Search
Now showing items 1-5 of 5
Prevalence of human immunodeficiency virus-1 drug-resistant mutations among adults on first- and second-line antiretroviral therapy in a resource-limited health facility in Busia County, Kenya
(Pan African Medical Journal, 2020-12)
Introduction: in Kenya, about 1.5 million people are living with the Human Immunodeficiency Virus (HIV). Antiretroviral therapy aids in viral suppression. However, drug-resistance threaten the gains of the HIV infection ...
HIV-1 Drug-Resistant Mutations in Relation to Virological Failure among Adults in Busia County, Kenya
(African Journal of Health Sciences, 2021-02-15)
Introduction: Busia County of Kenya with a Human Immune-deficiency Virus prevalence rate of 7.7% is two-fold higher than the Kenyan national prevalence at 4.9%. Antiretroviral (ARV) therapy is standard care for all HIV ...
Prevalence of human immunodeficiency virus-1 drug-resistant mutations among adults on first- and second-line antiretroviral therapy in a resource-limited health facility in Busia County, Kenya
(Pan African Medical Journal, 2020-12-03)
Introduction: in Kenya, about 1.5 million people are living with the Human Immunodeficiency Virus (HIV). Antiretroviral therapy aids in viral suppression. However, drug-resistance threaten the gains of the HIV infection ...
Prevalence of human immunodeficiency virus-1 drug-resistant mutations among adults on first- and second-line antiretroviral therapy in a resource-limited health facility in Busia County, Kenya
(Pan Afr Med J, 2020-12-03)
Introduction: in Kenya, about 1.5 million people are living with the Human Immunodeficiency Virus (HIV). Antiretroviral therapy aids in viral suppression. However, drug-resistance threaten the gains of the HIV infection ...
Correlation of HIV-1 drug resistant mutations and virologic failure
(Pan African Medical Journal, 2021-07-07)
Introduction: mutations are important by ensuring that the HIV-1 agent remains fit in the environment and evades drugs that are developed purposely to kill them. In Kenya, mutations conferring resistance to available ARVs ...